417 related articles for article (PubMed ID: 20931496)
1. [Interventional closure of persistent foramen ovale in patients after crytogenic stroke].
Chatterjee T; Akin I; Nienaber CA; Rehders TC; Ortak J; Chatterjee A; Ince H
Praxis (Bern 1994); 2010 Oct; 99(20):1203-15. PubMed ID: 20931496
[TBL] [Abstract][Full Text] [Related]
2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
3. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
4. Eliminating right-to-left shunt with patent foramen ovale closure: not as simple as it seems.
Rogers JH; Smith TW
JACC Cardiovasc Interv; 2009 Jun; 2(6):568-9. PubMed ID: 19539263
[No Abstract] [Full Text] [Related]
5. Successful Percutaneous Transcatheter Patent Foramen Ovale Closure Through The Right Internal Jugular Vein Using Stiff Amplatzer Catheter With A Reshaped Tip.
Fanari Z; Hammami S; Hopkins JT
Del Med J; 2016 Aug; 88(8):238-241. PubMed ID: 28751787
[TBL] [Abstract][Full Text] [Related]
6. A Review of Transcatheter Closure of Patent Foramen Ovale.
Neill J; Lin CH
Methodist Debakey Cardiovasc J; 2017; 13(3):152-159. PubMed ID: 29744000
[TBL] [Abstract][Full Text] [Related]
7. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study.
Rigatelli G; Dell'avvocata F; Braggion G; Giordan M; Chinaglia M; Cardaioli P
Catheter Cardiovasc Interv; 2008 Dec; 72(7):973-6. PubMed ID: 19021284
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler.
Jesurum JT; Fuller CJ; Renz J; Krabill KA; Spencer MP; Reisman M
JACC Cardiovasc Interv; 2009 Jun; 2(6):561-7. PubMed ID: 19539262
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
[TBL] [Abstract][Full Text] [Related]
10. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
[TBL] [Abstract][Full Text] [Related]
11. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders.
Collado FMS; Poulin MF; Murphy JJ; Jneid H; Kavinsky CJ
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910192
[No Abstract] [Full Text] [Related]
12. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
Mojadidi MK; Elgendy AY; Elgendy IY; Mahmoud AN; Elbadawi A; Eshtehardi P; Patel NK; Wayangankar S; Tobis JM; Meier B
JACC Cardiovasc Interv; 2017 Nov; 10(21):2228-2230. PubMed ID: 29122137
[No Abstract] [Full Text] [Related]
13. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL
Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934
[TBL] [Abstract][Full Text] [Related]
14. The Closure of Patent Foramen Ovale in Preventing Subsequent Neurological Events: A Bayesian Network Meta-Analysis to Identify the Best Device.
Varotto L; Bregolin G; Paccanaro M; De Boni A; Bonanno C; Perini F
Cerebrovasc Dis; 2020; 49(2):124-134. PubMed ID: 32289794
[TBL] [Abstract][Full Text] [Related]
15. Thrombus in a Hypercoagulable Patient Following Patent Foramen Ovale Closure With the Gore Septal Occluder.
Luc JGY; Bakar SN; Kiaii B; Sridhar K
JACC Cardiovasc Interv; 2018 Jun; 11(11):1108-1109. PubMed ID: 29778728
[No Abstract] [Full Text] [Related]
16. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
[TBL] [Abstract][Full Text] [Related]
17. Transcranial Doppler is Complementary to Echocardiography for Detection and Risk Stratification of Patent Foramen Ovale.
Tobe J; Bogiatzi C; Munoz C; Tamayo A; Spence JD
Can J Cardiol; 2016 Aug; 32(8):986.e9-986.e16. PubMed ID: 26952158
[TBL] [Abstract][Full Text] [Related]
18. AMPLATZER Septal Occluder failure resulting in paradoxical cerebral embolism.
Fernando RR; Koranne KP; Barker CM
Tex Heart Inst J; 2012; 39(5):647-52. PubMed ID: 23109759
[TBL] [Abstract][Full Text] [Related]
19. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex occluder device with conjunctive intensified anticoagulation regimen.
Fischer D; Fuchs M; Schaefer A; Schieffer B; Jategaonkar S; Hornig B; Drexler H; Meyer GP
J Interv Cardiol; 2008 Apr; 21(2):183-9. PubMed ID: 18312307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]